Metraipolis › archive › dc_097ed0b59b35
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter,… — Europe PMC PMID:40836376
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40836376
- DOI
- 10.1111/ijd.70027
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T12:19:01.174Z
- SHA-256 of the archived text
ffbfea662a43061f615d5edeca1f4408f1d28b82b07980e0c95e133312c0d1a7- Stable URL of this page
https://metraipolis.com/documento/dc_097ed0b59b35
How to cite
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter,… — Europe PMC PMID:40836376 — Europe PMC (en), https://europepmc.org/article/MED/40836376 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_097ed0b59b35 (Metraipolis archive dc_097ed0b59b35, sha256 ffbfea662a43061f615d5edeca1f4408f1d28b82b07980e0c95e133312c0d1a7)
BibTeX
@misc{dc097ed0b59b35,
title = {Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter,… — Europe PMC PMID:40836376},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40836376},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_097ed0b59b35; sha256 ffbfea662a43061f615d5edeca1f4408f1d28b82b07980e0c95e133312c0d1a7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40836376. Agents can read the archived copy with the MCP tool read_document.